Host: Stephen Krieger, MD Guest: Tirisham Gyang, MD Guest: Augusto Miravalle, MD, FAAN New strategies for early intervention in multiple sclerosis (MS) are focusing on progression independent of relapse. These strategies include incorpor

Host: Caitlin Costello, MD Guest: Sagar Lonial, MD, FACP Bispecific antibodies are the newest immunotherapies approved for heavily pretreated relapsed/refractory myeloma, and they are shown to double response rates. Are you ready to use them

Host: David J. Kuter, MD, DPhil Guest: Spero R. Cataland, MD Guest: Catherine Broome, MD Guest: Cindy Neunert, MD, MSCS Because immune-mediated rare blood disorders are uncommon, healthcare providers often lack the knowledge and expe

Host: Helena Yu, MD Dr. Helena Yu of Memorial Sloan Kettering Cancer Center presents an insightful overview of HER2 targeted therapy in non-small cell lung cancer (NSCLC), emphasizing the critical role of broad molecular profiling in ensuring ef

Host: Benjamin Levy, MD Guest: Alexander Spira, MD, PhD, FACP Drs. Benjamin Levy and Alex Spira discuss the emerging role of TROP2 as a therapeutic target in non-small cell lung cancer (NSCLC) on ReachMD. They delve into the mechanisms and c

Host: Jyoti Patel, MD Guest: Pasi Antero Jnne, MD, PhD Dive into the forefront of precision oncology with Drs. Pasi Janne and Jyoti Patel, where they unravel the potential of HER3-directed antibody-drug conjugates (ADCs) in revolutionizing

Host: Caitlin Costello, MD Guest: Sagar Lonial, MD, FACP Dive into the cutting-edge realm of bispecific antibodies for relapsed/refractory multiple myeloma with our experts, Dr. Caitlin Costello and Dr. Sagar Lonial. They explore the efficac

Host: Naomi Fisher, MD Guest: Florian Rader, MD Dive into the realm of hypertension management through a chapterized expert interview CME activity on ultrasound renal denervation. In the first chapter, explore the significance of addressing

Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma is a multiepisodic CME series exploring the role of bispecific antibodies for the treat

Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma is a multiepisodic CME series exploring the role of bispecific antibodies for the treat